Lack of association of IDH1, IDH2 and DNMT3A mutations with outcome in older patients with acute myeloid leukemia treated with hypomethylating agents

被引:54
作者
DiNardo, Courtney D. [1 ]
Patel, Keyur P. [2 ]
Garcia-Manero, Guillermo [1 ]
Luthra, Rajyalakshmi [2 ]
Pierce, Sherry [1 ]
Borthakur, Gautam [1 ]
Jabbour, Elias [1 ]
Kadia, Tapan [1 ]
Pemmaraju, Naveen [1 ]
Konopleva, Marina [1 ]
Faderl, Stefan [1 ]
Cortes, Jorge [1 ]
Kantarjian, Hagop M. [1 ]
Ravandi, Farhad [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
关键词
MYELODYSPLASTIC SYNDROMES; PROGNOSTIC-SIGNIFICANCE; DOSE CYTARABINE; TET2; AML; AZACITIDINE; IMPACT; ADULTS; GENE; CARE;
D O I
10.3109/10428194.2013.855309
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1925 / 1929
页数:5
相关论文
共 27 条
[1]   Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies [J].
Abdel-Wahab, Omar ;
Mullally, Ann ;
Hedvat, Cyrus ;
Garcia-Manero, Guillermo ;
Patel, Jay ;
Wadleigh, Martha ;
Malinge, Sebastien ;
Yao, JinJuan ;
Kilpivaara, Outi ;
Bhat, Rukhmi ;
Huberman, Kety ;
Thomas, Sabrena ;
Dolgalev, Igor ;
Heguy, Adriana ;
Paietta, Elisabeth ;
Le Beau, Michelle M. ;
Beran, Miloslav ;
Tallman, Martin S. ;
Ebert, Benjamin L. ;
Kantarjian, Hagop M. ;
Stone, Richard M. ;
Gilliland, D. Gary ;
Crispino, John D. ;
Levine, Ross L. .
BLOOD, 2009, 114 (01) :144-147
[2]  
[Anonymous], HEMATOLOGY AM SOC HE
[3]   TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics [J].
Chou, Wen-Chien ;
Chou, Sheng-Chieh ;
Liu, Chieh-Yu ;
Chen, Chien-Yuan ;
Hou, Hsin-An ;
Kuo, Yuan-Yeh ;
Lee, Ming-Cheng ;
Ko, Bor-Sheng ;
Tang, Jih-Luh ;
Yao, Ming ;
Tsay, Woei ;
Wu, Shang-Ju ;
Huang, Shang-Yi ;
Hsu, Szu-Chun ;
Chen, Yao-Chang ;
Chang, Yi-Chang ;
Kuo, Yi-Yi ;
Kuo, Kuan-Ting ;
Lee, Fen-Yu ;
Liu, Ming-Chi ;
Liu, Chia-Wen ;
Tseng, Mei-Hsuan ;
Huang, Chi-Fei ;
Tien, Hwei-Fang .
BLOOD, 2011, 118 (14) :3803-3810
[4]   Mutation in TET2 in Myeloid Cancers [J].
Delhommeau, Francois ;
Dupont, Sabrina ;
Della Valle, Veronique ;
James, Chloe ;
Trannoy, Severine ;
Masse, Aline ;
Kosmider, Olivier ;
Le Couedic, Jean-Pierre ;
Robert, Fabienne ;
Alberdi, Antonio ;
Lecluse, Yann ;
Plo, Isabelle ;
Dreyfus, Francois J. ;
Marzac, Christophe ;
Casadevall, Nicole ;
Lacombe, Catherine ;
Romana, Serge P. ;
Dessen, Philippe ;
Soulier, Jean ;
Viguie, Franck ;
Fontenay, Michaela ;
Vainchenker, William ;
Bernard, Olivier A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (22) :2289-2301
[5]   Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet [J].
Doehner, Hartmut ;
Estey, Elihu H. ;
Amadori, Sergio ;
Appelbaum, Frederick R. ;
Buechner, Thomas ;
Burnett, Alan K. ;
Dombret, Herve ;
Fenaux, Pierre ;
Grimwade, David ;
Larson, Richard A. ;
Lo-Coco, Francesco ;
Naoe, Tomoki ;
Niederwieser, Dietger ;
Ossenkoppele, Gert J. ;
Sanz, Miguel A. ;
Sierra, Jorge ;
Tallman, Martin S. ;
Loewenberg, Bob ;
Bloomfield, Clara D. .
BLOOD, 2010, 115 (03) :453-474
[6]   Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders [J].
Ernst, Thomas ;
Chase, Andrew J. ;
Score, Joannah ;
Hidalgo-Curtis, Claire E. ;
Bryant, Catherine ;
Jones, Amy V. ;
Waghorn, Katherine ;
Zoi, Katerina ;
Ross, Fiona M. ;
Reiter, Andreas ;
Hochhaus, Andreas ;
Drexler, Hans G. ;
Duncombe, Andrew ;
Cervantes, Francisco ;
Oscier, David ;
Boultwood, Jacqueline ;
Grand, Francis H. ;
Cross, Nicholas C. P. .
NATURE GENETICS, 2010, 42 (08) :722-U109
[7]   Acute myeloid leukemia and myelodysplastic syndromes in older patients [J].
Estey, Elihu .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (14) :1908-1915
[8]   Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia [J].
Fenaux, Pierre ;
Mufti, Ghulam J. ;
Hellstrom-Lindberg, Eva ;
Santini, Valeria ;
Gattermann, Norbert ;
Germing, Ulrich ;
Sanz, Guillermo ;
List, Alan F. ;
Gore, Steven ;
Seymour, John F. ;
Dombret, Herve ;
Backstrom, Jay ;
Zimmerman, Linda ;
McKenzie, David ;
Beach, C. L. ;
Silverman, Lewis R. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (04) :562-569
[9]   Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation [J].
Figueroa, Maria E. ;
Abdel-Wahab, Omar ;
Lu, Chao ;
Ward, Patrick S. ;
Patel, Jay ;
Shih, Alan ;
Li, Yushan ;
Bhagwat, Neha ;
Vasanthakumar, Aparna ;
Fernandez, Hugo F. ;
Tallman, Martin S. ;
Sun, Zhuoxin ;
Wolniak, Kristy ;
Peeters, Justine K. ;
Liu, Wei ;
Choe, Sung E. ;
Fantin, Valeria R. ;
Paietta, Elisabeth ;
Lowenberg, Bob ;
Licht, Jonathan D. ;
Godley, Lucy A. ;
Delwel, Ruud ;
Valk, Peter J. M. ;
Thompson, Craig B. ;
Levine, Ross L. ;
Melnick, An .
CANCER CELL, 2010, 18 (06) :553-567
[10]   The prognostic significance of IDH2 mutations in AML depends on the location of the mutation [J].
Green, Claire L. ;
Evans, Catherine M. ;
Zhao, Lu ;
Hills, Robert K. ;
Burnett, Alan K. ;
Linch, David C. ;
Gale, Rosemary E. .
BLOOD, 2011, 118 (02) :409-412